Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2020 | 01-2020 | 10-2019 | 07-2019 | 04-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,195 | -15,335 | -7,648 | 2,489 | 7,876 |
| Depreciation Amortization | 2,151 | 1,434 | 725 | 3,036 | 2,372 |
| Accounts receivable | 3,942 | 1,848 | 890 | 2,404 | 1,605 |
| Accounts payable and accrued liabilities | 1,211 | 877 | 1,325 | -2,508 | -3,363 |
| Other Working Capital | 9,559 | 5,295 | 4,855 | -3,006 | -4,103 |
| Other Operating Activity | -3,786 | -2,110 | -2,213 | 2,391 | 3,594 |
| Operating Cash Flow | $-12,118 | $-7,991 | $-2,066 | $4,806 | $7,981 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -719 | -434 | -274 | -8,126 | -7,554 |
| Investing Cash Flow | $-719 | $-434 | $-274 | $-8,126 | $-7,554 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 4,500 |
| Debt Issued | 7,412 | N/A | N/A | 4,500 | N/A |
| Debt Repayment | -321 | -229 | -105 | -404 | -244 |
| Common Stock Issued | N/A | N/A | N/A | 167 | 166 |
| Other Financing Activity | 0 | 0 | -66 | -70 | -72 |
| Financing Cash Flow | $7,091 | $-229 | $-171 | $4,193 | $4,350 |
| Exchange Rate Effect | 7 | 10 | 8 | -18 | -16 |
| Beginning Cash Position | 60,896 | 60,896 | 60,146 | 60,041 | 60,041 |
| End Cash Position | 55,157 | 52,252 | 57,643 | 60,896 | 64,802 |
| Net Cash Flow | $-5,739 | $-8,644 | $-2,503 | $855 | $4,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,118 | -7,991 | -2,066 | 4,806 | 7,981 |
| Capital Expenditure | -719 | -434 | -274 | -8,126 | -7,554 |
| Free Cash Flow | -12,837 | -8,425 | -2,340 | -3,320 | 427 |